glp-1 agonists oral FDA just approved orforglipron (Foundayo), Eli Lilly's receptor agonist for obesity. In the ATTAIN-1 phase 3 trial (n=3,127), published in the New England Journal of Medicine, patients on the highest GLP-1 Agonists Explained: Definition, How

New strategies for the development of antifungal drugs have gradually become a research hotspot, including the targeting of novel biological pathways, the combination of antifungal drugs, the development of fungal vaccines, the creation of innovative therapeutics (such as small-molecule peptides and nanoparticles), the extraction of active ingredients from traditional Chinese medicine, and the utilization of artificial intelligence in drug design ( Figure 1 ) (Wall and Lopez-Ribot, 2020

Ruiz-Maldonado R, Tamayo L, Laterza AM, Durn C

Endpoints for clinical trials in ophthalmology

Reduce joint pain: Prioritize regular strength training and low-impact movement, get plenty of omega-3s, and take NSAIDs like aspirin or ibuprofen as needed or as directed by your healthcare professional